Literature DB >> 14707648

Selective recruitment of endothelial progenitor cells to ischemic tissues with increased neovascularization.

Sanghoon Park1, Oren M Tepper, Robert D Galiano, Jennifer M Capla, Samuel Baharestani, Mark E Kleinman, Catherine R Pelo, Jamie P Levine, Geoffrey C Gurtner.   

Abstract

Tissue ischemia remains a common problem in plastic surgery and one for which proangiogenic approaches have been investigated. Given the recent discovery of circulating endothelial stem or progenitor cells that are able to form new blood vessels, the authors sought to determine whether these cells might selectively traffic to regions of tissue ischemia and induce neovascularization. Endothelial progenitor cells were isolated from the peripheral blood of healthy human volunteers and expanded ex vivo for 7 days. Elevation of a cranially based random-pattern skin flap was performed in nude mice, after which they were injected with fluorescent-labeled endothelial progenitor cells (5 x 10(5); n = 15), fluorescent-labeled human microvascular endothelial cells (5 x 10(5); n = 15), or media alone (n = 15). Histologic examination demonstrated that endothelial progenitor cells were recruited to ischemic tissue and first appeared by postoperative day 3. Subsequently, endothelial progenitor cell numbers increased exponentially over time for the remainder of the study [0 cells/mm2 at day 0 (n = 3), 9.6 +/- 0.9 cells/mm2 at day 3 (n = 3), 24.6 +/- 1.5 cells/mm2 at day 7 (n = 3), and 196.3 +/- 9.6 cells/mm2 at day 14 (n = 9)]. At all time points, endothelial progenitor cells localized preferentially to ischemic tissue and healing wound edges, and were not observed in normal, uninjured tissues. Endothelial progenitor cell transplantation led to a statistically significant increase in vascular density in ischemic tissues by postoperative day 14 [28.7 +/- 1.2 in the endothelial progenitor cell group (n = 9) versus 18 +/- 1.1 in the control media group (n = 9) and 17.7 +/- 1.0 in the human microvascular endothelial cell group (n = 9; p < 0.01)]. Endothelial progenitor cell transplantation also showed trends toward increased flap survival [171.2 +/- 18 mm2 in the endothelial progenitor cell group (n = 12) versus 134.2 +/- 10 mm2 in the media group (n = 12) and 145.0 +/- 13 mm2 in the human microvascular endothelial cell group (n = 12)], but this did not reach statistical significance. These findings indicate that local tissue ischemia is a potent stimulus for the recruitment of circulating endothelial progenitor cells. Systemic delivery of endothelial progenitor cells increased neovascularization and suggests that autologous endothelial progenitor cell transplantation may have a role in the salvage of ischemic tissue.

Entities:  

Mesh:

Year:  2004        PMID: 14707648     DOI: 10.1097/01.PRS.0000091169.51035.A5

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  14 in total

1.  Increased endothelial progenitor cells and vasculogenic factors in higher-staged arteriovenous malformations.

Authors:  Lingge Lu; Joyce Bischoff; John B Mulliken; Diane R Bielenberg; Steven J Fishman; Arin K Greene
Journal:  Plast Reconstr Surg       Date:  2011-10       Impact factor: 4.730

2.  Macrophage Recruitment and Polarization During Collateral Vessel Remodeling in Murine Adipose Tissue.

Authors:  Scott A Seaman; Yiqi Cao; Chris A Campbell; Shayn M Peirce
Journal:  Microcirculation       Date:  2016-01       Impact factor: 2.628

3.  Endothelial progenitor cells are integrated in newly formed capillaries and alter adjacent fibrovascular tissue after subcutaneous implantation in a fibrin matrix.

Authors:  Oliver Bleiziffer; Matthias Hammon; Elisabeth Naschberger; Karoline Lipnik; Andreas Arkudas; Subha Rath; Galyna Pryymachuk; Justus P Beier; Michael Stürzl; Raymund E Horch; Ulrich Kneser
Journal:  J Cell Mol Med       Date:  2011-11       Impact factor: 5.310

4.  Low dose cranial irradiation-induced cerebrovascular damage is reversible in mice.

Authors:  Nikolett Sándor; Fruzsina R Walter; Alexandra Bocsik; Petra Sántha; Boglárka Schilling-Tóth; Violetta Léner; Zoltán Varga; Zsuzsanna Kahán; Mária A Deli; Géza Sáfrány; Hargita Hegyesi
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

5.  Effect of endogenous bone marrow derived stem cells induced by AMD-3100 on expanded ischemic flap.

Authors:  Hii-Sun Jeong; Hye-Kyung Lee; Kwan-Chul Tark; Dae-Hyun Lew; Yoon-Woo Koh; Chul-Hoon Kim; In-Suck Seo
Journal:  J Korean Med Sci       Date:  2014-11-21       Impact factor: 2.153

6.  T17b murine embryonal endothelial progenitor cells can be induced towards both proliferation and differentiation in a fibrin matrix.

Authors:  Oliver Bleiziffer; Raymund E Horch; Matthias Hammon; Andreas Arkudas; Elisabeth Naschberger; Subha Rath; Galyna Pryymachuk; Justus P Beier; Antonis K Hatzopoulos; Michael Stürzl; Ulrich Kneser
Journal:  J Cell Mol Med       Date:  2009-05       Impact factor: 5.310

Review 7.  Stem cell therapy for lower extremity diabetic ulcers: where do we stand?

Authors:  Mei Yang; Lingling Sheng; Tian R Zhang; Qingfeng Li
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

8.  Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury.

Authors:  Christian M Kähler; Jutta Wechselberger; Wolfgang Hilbe; Andreas Gschwendtner; Daniela Colleselli; Harald Niederegger; Eva-Maria Boneberg; Gilbert Spizzo; Albrecht Wendel; Eberhard Gunsilius; Josef R Patsch; Jürg Hamacher
Journal:  Respir Res       Date:  2007-07-09

9.  Quality-control culture system restores diabetic endothelial progenitor cell vasculogenesis and accelerates wound closure.

Authors:  Rica Tanaka; Max Vaynrub; Haruchika Masuda; Rie Ito; Michiru Kobori; Muneo Miyasaka; Hiroshi Mizuno; Stephen M Warren; Takayuki Asahara
Journal:  Diabetes       Date:  2013-05-13       Impact factor: 9.461

10.  R2* and R2 mapping for quantifying recruitment of superparamagnetic iron oxide-tagged endothelial progenitor cells to injured liver: tracking in vitro and in vivo.

Authors:  Qingguo Wang; Kangan Li; Qimeng Quan; Guixiang Zhang
Journal:  Int J Nanomedicine       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.